Your browser doesn't support javascript.
loading
Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
Gono, Takahisa; Kaneko, Hirotaka; Kawaguchi, Yasushi; Hanaoka, Masanori; Kataoka, Sayuri; Kuwana, Masataka; Takagi, Kae; Ichida, Hisae; Katsumata, Yasuhiro; Ota, Yuko; Kawasumi, Hidenaga; Yamanaka, Hisashi.
Afiliação
  • Gono T; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kaneko H; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kawaguchi Y; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. y-kawa@ior.twmu.ac.jp.
  • Hanaoka M; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kataoka S; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kuwana M; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Takagi K; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Ichida H; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Katsumata Y; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Ota Y; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kawasumi H; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Yamanaka H; Institute of Rheumatology, Tokyo Women's Medical University and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Rheumatology (Oxford) ; 53(12): 2196-203, 2014 Dec.
Article em En | MEDLINE | ID: mdl-24970922
OBJECTIVE: PM and DM are often complicated by interstitial lung disease (ILD). In this study we aimed to evaluate various serum cytokines in patients with PM/DM with ILD so as to clarify the differences in pathophysiology between anti-melanoma differentiation-associated gene 5 antibody-associated ILD (anti-MDA5-ILD) and anti-aminoacyl tRNA synthetase antibody-associated ILD (anti-ARS-ILD). METHODS: We evaluated the serum cytokine profiles of 38 patients with PM/DM and compared the cytokine profiles of the non-ILD and ILD subsets as well as the anti-MDA5-ILD and anti-ARS-ILD subsets. RESULTS: The myositis intention-to-treat activity index score, which indicates whole disease activity, significantly correlated with serum IL-6, IL-8, TNF-α and IP-10. These cytokine levels were significantly higher in the ILD subset than the non-ILD subset and were lower in the ILD subset following treatment. By multivariate analysis, TNF-α was the most significant cytokine [P = 0.0006, odds ratio (OR) 1.4, CI 1.1, 2.2] associated with PM/DM with ILD. IL-8 levels were significantly higher in anti-MDA5-ILD than in anti-ARS-ILD, although IL-6, TNF-α and IP-10 levels were high in both subsets. IL-8 was the most significant cytokine (P = 0.0006, OR 1.5, CI 1.1, 3.0) associated with anti-MDA5-ILD by multivariate analysis. Moreover, the ratio of IL-4 to IFN-γ was lower in anti-MDA5-ILD than in anti-ARS-ILD. CONCLUSION: IL-6, IL-8, TNF-α and IP-10 are associated with global disease activity in PM/DM. These cytokine levels were high, especially in the ILD subset. Serum IL-8 levels and the balance between IL-4 and IFN-γ may contribute to the differences in pathophysiology between anti-ARS-ILD and anti-MDA5-ILD.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citocinas / Polimiosite / Doenças Pulmonares Intersticiais / Dermatomiosite Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citocinas / Polimiosite / Doenças Pulmonares Intersticiais / Dermatomiosite Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article